Literature DB >> 28974803

Antidiabetic and antioxidant functionality associated with phenolic constituents from fruit parts of indigenous black jamun (Syzygium cumini L.) landraces.

H P Gajera1, Shila N Gevariya1, Darshna G Hirpara1, S V Patel1, B A Golakiya1.   

Abstract

ABSTRACT: Fruit phenolics are important dietary antioxidant and antidiabetic constituents. The fruit parts (pulp, seed, seed coat, kernel) of underutilized indigenous six black jamun landraces (Syzygium cumini L.), found in Gir forest region of India and differed in their fruit size, shape and weight, are evaluated and correlated with antidiabetic, DPPH radical scavenging and phenolic constituents. The α-amylase inhibitors propose an efficient antidiabetic strategy and the levels of postprandial hyperglycemia were lowered by restraining starch breakdown. The sequential solvent systems with ascending polarity-petroleum ether, ethyl acetate, methanol and water were performed for soxhlet extraction by hot percolation method and extractive yield was found maximum with methanolic fruit part extracts of six landraces. The methanolic extracts of fruit parts also evidenced higher antidiabetic activity and hence utilized for further characterization. Among the six landraces, pulp and kernel of BJLR-6 (very small, oblong fruits) evidenced maximum 53.8 and 98.2% inhibition of α-amylase activity, respectively. The seed attained inhibitory activity mostly contributed by the kernel fraction. The inhibition of DPPH radical scavenging activity was positively correlated with phenol constituents. An HPLC-PDA technique was used to quantify the seven individual phenolics. The seed and kernel of BJLR-6 exhibited higher individual phenolics-gallic, catechin, ellagic, ferulic acids and quercetin, whereas pulp evidenced higher with gallic acid and catechin as α-amylase inhibitors. The IC50 value indicates concentration of fruit extracts exhibiting ≥50% inhibition on porcine pancreatic α-amylase (PPA) activity. The kernel fraction of BJLR6 evidenced lowest (8.3 µg ml-1) IC50 value followed by seed (12.9 µg ml-1), seed coat (50.8 µg ml-1) and pulp (270 µg ml-1). The seed and kernel of BJLR-6 inhibited PPA at much lower concentrations than standard acarbose (24.7 µg ml-1) considering good candidates for antidiabetic herbal formulations.

Entities:  

Keywords:  Antioxidant activity; Fruit parts; HPLC profile; Herbal formulation; Syzygium cumini L.; α-Amylase inhibition

Year:  2017        PMID: 28974803      PMCID: PMC5602981          DOI: 10.1007/s13197-017-2756-8

Source DB:  PubMed          Journal:  J Food Sci Technol        ISSN: 0022-1155            Impact factor:   2.701


  27 in total

1.  Anti-hyperglycemic effect of Eugenia jambolana and Tinospora cordifolia in experimental diabetes and their effects on key metabolic enzymes involved in carbohydrate metabolism.

Authors:  J K Grover; V Vats; S S Rathi
Journal:  J Ethnopharmacol       Date:  2000-12       Impact factor: 4.360

Review 2.  Coffee and type 2 diabetes: from beans to beta-cells.

Authors:  R M van Dam
Journal:  Nutr Metab Cardiovasc Dis       Date:  2005-12-13       Impact factor: 4.222

3.  Screening of traditional antidiabetic medicinal plants of Mauritius for possible alpha-amylase inhibitory effects in vitro.

Authors:  M I Kotowaroo; M F Mahomoodally; A Gurib-Fakim; A H Subratty
Journal:  Phytother Res       Date:  2006-03       Impact factor: 5.878

4.  Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice.

Authors:  Un Ju Jung; Mi-Kyung Lee; Yong Bok Park; Seon-Min Jeon; Myung-Sook Choi
Journal:  J Pharmacol Exp Ther       Date:  2006-04-27       Impact factor: 4.030

5.  Antioxidant activity in medicinal plants associated with the symptoms of diabetes mellitus used by the indigenous peoples of the North American boreal forest.

Authors:  Letitia M McCune; Timothy Johns
Journal:  J Ethnopharmacol       Date:  2002-10       Impact factor: 4.360

6.  Evaluation of traditional Indian antidiabetic medicinal plants for human pancreatic amylase inhibitory effect in vitro.

Authors:  Sudha Ponnusamy; Remya Ravindran; Smita Zinjarde; Shobha Bhargava; Ameeta Ravi Kumar
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-23       Impact factor: 2.629

7.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

8.  Protective effect of gallic acid and Syzygium cumini extract against oxidative stress-induced cellular injury in human lymphocytes.

Authors:  Karine Santos De Bona; Gabriela Bonfanti; Paula Eliete Rodrigues Bitencourt; Thainan Paz da Silva; Raphaela Maleski Borges; Aline Boligon; Aline Pigatto; Margareth Lynde Athayde; Maria Beatriz Moretto
Journal:  Drug Chem Toxicol       Date:  2015-09-12       Impact factor: 3.356

9.  Protective effects of ferulic acid on hyperlipidemic diabetic rats.

Authors:  M Sri Balasubashini; R Rukkumani; V P Menon
Journal:  Acta Diabetol       Date:  2003-09       Impact factor: 4.280

10.  A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes.

Authors:  Tomonori Nagao; Shinichi Meguro; Tadashi Hase; Kazuhiro Otsuka; Masanori Komikado; Ichiro Tokimitsu; Takashi Yamamoto; Kunio Yamamoto
Journal:  Obesity (Silver Spring)       Date:  2008-11-13       Impact factor: 5.002

View more
  2 in total

1.  Bioactive Properties of Syzygium cumini (L.) Skeels Pulp and Seed Phenolic Extracts.

Authors:  Catarina A Santos; Felipe A Almeida; Beatriz X V Quecán; Patricia A P Pereira; Kelly M B Gandra; Luciana R Cunha; Uelinton M Pinto
Journal:  Front Microbiol       Date:  2020-05-27       Impact factor: 5.640

Review 2.  Neuroprotective Potential of Ellagic Acid: A Critical Review.

Authors:  Ashutosh Gupta; Amit Kumar Singh; Ramesh Kumar; Sarah Jamieson; Abhay Kumar Pandey; Anupam Bishayee
Journal:  Adv Nutr       Date:  2021-07-30       Impact factor: 8.701

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.